Paul Tudor Jones’s Revolution Medicines RVMD Stock Holding History

Paul Tudor Jones’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3M	Sell	16,000 -71,852	-82%	-$10.5M	﹤0.01%	1659
2026 Q1	$8.54M	Sell	87,852 -4,539	-5%	-$458K	0.02%	828
2025 Q4	$7.36M	Buy	+92,391	New	+$6.06M	0.01%	921
2025 Q3	–	Sell	-35,185	Closed	-$1.29M	–	3806
2025 Q2	$1.29M	Buy	+35,185	New	+$1.35M	﹤0.01%	1966
2024 Q4	–	Sell	-38,306	Closed	-$1.74M	–	3443
2024 Q3	$1.74M	Buy	+38,306	New	+$1.67M	0.01%	1283
2023 Q3	–	Sell	-13,583	Closed	-$363K	–	2786
2023 Q2	$363K	Buy	13,583 +69	+0.5%	+$1.69K	﹤0.01%	1890
2023 Q1	$293K	Buy	13,514 +4,075	+43%	+$100K	﹤0.01%	1949
2022 Q4	$225K	Buy	+9,439	New	+$201K	﹤0.01%	2074
2022 Q3	–	Sell	-22,998	Closed	-$448K	–	2643
2022 Q2	$448K	Sell	22,998 -44,723	-66%	-$871K	0.01%	1334
2022 Q1	$1.73M	Buy	+67,721	New	+$1.47M	0.04%	627
2021 Q3	–	Sell	-75,797	Closed	-$2.41M	–	2754
2021 Q2	$2.41M	Buy	+75,797	New	+$2.65M	0.05%	487

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Paul Tudor Jones's RVMD Position: Q2 2026 in Review

Paul Tudor Jones reduced its Revolution Medicines (RVMD) stake by 82% in Q2 2026, selling an estimated $10.5M and leaving 16,000 shares worth $3M. The position accounts for ﹤0.01% of the portfolio, ranked #1659.

Paul Tudor Jones first reported a position in RVMD in Q2 2021 and has held it in 11 quarters since. The position peaked at $8.54M in Q1 2026. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Paul Tudor Jones held 16,000 shares of Revolution Medicines worth $3M as of Q2 2026.
Paul Tudor Jones sold 71,852 Revolution Medicines shares in Q2 2026, an estimated $10.5M.
Revolution Medicines made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1659 holding.
Paul Tudor Jones first reported a position in Revolution Medicines in Q2 2021 and has held it in 11 quarters since.
Paul Tudor Jones's Revolution Medicines position peaked at $8.54M in Q1 2026.
688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.